Rocket Pharmaceuticals (NASDAQ:RCKT) reported quarterly losses of $(0.83) per share. This is a 50.91 percent decrease over losses of $(0.55) per share from the same period last year.
Oracle, J. M. Smucker And A Tech ETF Up 43% This Year: CNBC’s ‘Final Trades’
On CNBC’s "Halftime Report Final Trades," Jim Lebenthal of Cerity Partners named Oracle Corporation (NYSE: ORCL) as